A homogeneous assay system of aspartate aminotransferase iso-enzymes using proteases and application for clinical evaluation of myocardial infarction

J Clin Lab Anal. 1992;6(6):362-7. doi: 10.1002/jcla.1860060605.

Abstract

We designed a rapid, homogeneous assay for human aspartate aminotransferase (AST) isoenzymes, by a selective proteolysis of soluble AST (s-AST), using chymotrypsin and protease 401. The linearity of mitochondrial (m-AST) was elongated up to 4000 U/l. m-AST values from the human liver, and determined by a homogeneous assay using protease 401 or chymotrypsin, were relative to those obtained using an immunoprecipitation method. In perioperative patients or those with an acute myocardial infarction, the peaks of s-AST and m-AST values were noted 13 h and at 57 h after ictus, respectively, whereas the peak of ratio between was seen 6 h after ictus. In the case of Budd-Chiari syndrome, the maximum levels of the two AST activities were evident 14 days after hospitalization and the peak of ratio between them was seen after 7 days. We propose that this homogeneous assay can serve as a diagnostic tool for early phase detection of myocardial infarction and of Budd-Chiari syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Aspartate Aminotransferases / analysis*
  • Aspartate Aminotransferases / antagonists & inhibitors
  • Biomarkers / analysis
  • Budd-Chiari Syndrome / diagnosis
  • Budd-Chiari Syndrome / enzymology
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Isoenzymes / analysis*
  • Isoenzymes / antagonists & inhibitors
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnosis*
  • Myocardial Infarction / enzymology
  • Reference Values
  • Serine Endopeptidases

Substances

  • Biomarkers
  • Isoenzymes
  • Aspartate Aminotransferases
  • Serine Endopeptidases